Utility of CHA2DS2-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients. Okubo A, Doi T, Morii K, Nishizawa Y, et al. Am J Nephrol 2022 Mar 8:1-7. doi: 10.1159/000522225.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Okubo A, Doi T, Morii K, Nishizawa Y, et al. Utility of CHA2DS2-VASc Score to Predict Mid-Term Clinical Outcomes in Hemodialysis Patients. Am J Nephrol 2022 Mar 8:1-7. doi: 10.1159/000522225.
PMID: 35259747